Paul W. Hoelscher

Insider Reports History

Location
Deerfield, IL
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul W. Hoelscher:

Company Role Class Num Shares Value Price $ Report Date Ownership
Horizon Therapeutics Public Ltd Co EVP, CFO Ordinary Shares 72,789 $8,479,919 $116.50 20 Apr 2022 By Trust
Horizon Therapeutics Public Ltd Co EVP, CFO Ordinary Shares 66,673 $7,767,405 $116.50 20 Apr 2022 By LLC
Horizon Therapeutics Public Ltd Co EVP, CFO Ordinary Shares 1,049 $122,209 $116.50 20 Apr 2022 Direct
Horizon Therapeutics Public Ltd Co EVP, CFO Stock Option (Right to Buy) 36,424 20 Apr 2022 Direct
Sagimet Biosciences Inc. Director Stock Option (Right to Buy) 32,250 09 Jun 2025 Direct
Reneo Pharmaceuticals, Inc. Director Stock Option (right to buy) 17,500 06 Jun 2023 Direct

Insider Reports Filed by Paul W. Hoelscher

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMT Sagimet Biosciences Inc. 09 Jun 2025 1 $0 4 Director 10 Jun 2025, 17:37
SGMT Sagimet Biosciences Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:05
SGMT Sagimet Biosciences Inc. 01 Apr 2024 1 $0 4 Director 03 Apr 2024, 20:17
SGMT Sagimet Biosciences Inc. 01 Apr 2024 0 $0 3 Director 03 Apr 2024, 20:13
OKUR Reneo Pharmaceuticals, Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 18:15
OKUR Reneo Pharmaceuticals, Inc. 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 17:00
/report/000120919122025455-hoelscher-paul-w-2022-04-20 Horizon Therapeutics Public Ltd Co 20 Apr 2022 4 -$4,628,449 4 EVP, CFO 22 Apr 2022, 18:47
/report/000120919122023845-hoelscher-paul-w-2022-04-06 Horizon Therapeutics Public Ltd Co 06 Apr 2022 6 -$29,197,397 4 EVP, CFO 08 Apr 2022, 16:09
/report/000120919122021151-hoelscher-paul-w-2022-03-23 Horizon Therapeutics Public Ltd Co 23 Mar 2022 10 -$3,976,463 4 EVP, CFO 25 Mar 2022, 18:38
/report/000120919122004633-hoelscher-paul-w-2022-01-21 Horizon Therapeutics Public Ltd Co 21 Jan 2022 3 -$212,852 4 EVP, CFO 24 Jan 2022, 16:06
OKUR Reneo Pharmaceuticals, Inc. 20 Jan 2022 1 $0 4 Director 24 Jan 2022, 15:58
OKUR Reneo Pharmaceuticals, Inc. 20 Jan 2022 0 $0 3 Director 24 Jan 2022, 15:55
/report/000120919122002291-hoelscher-paul-w-2022-01-04 Horizon Therapeutics Public Ltd Co 04 Jan 2022 9 -$5,159,825 4 EVP, CFO 06 Jan 2022, 19:58
/report/000120919121071650-hoelscher-paul-w-2021-12-28 Horizon Therapeutics Public Ltd Co 28 Dec 2021 6 -$806,393 4 EVP, CFO 30 Dec 2021, 20:00
/report/000120919121048788-hoelscher-paul-w-2021-07-28 Horizon Therapeutics Public Ltd Co 28 Jul 2021 3 -$395,445 4 EVP, CFO 30 Jul 2021, 16:25
/report/000120919121032882-hoelscher-paul-w-2021-05-14 Horizon Therapeutics Public Ltd Co 14 May 2021 1 -$9,263,847 4 EVP, CFO 14 May 2021, 18:12